Literature DB >> 36258249

The state of health in Belgium, 1990-2019: a benchmarking analysis based on the Global Burden of Disease 2019 study.

Jinane Ghattas1, Vanessa Gorasso2,3, Robby De Pauw2,4, Sophie Thunus1, Niko Speybroeck1, Brecht Devleesschauwer5,6.   

Abstract

BACKGROUND: In a context of decreasing resources and growing health needs, evidence-based health and care policies are essential. This study aims to assess the health trends in Belgium between 1990 and 2019, to compare the Belgian health status to that of the EU-15 countries, and to identify the main drivers in trends over time and country differences within the EU-15.
METHODS: We extracted estimates from the GBD 2019 study via the GBD results tool and visualization tools. We compared the Belgian health status with 14 European Union comparator countries between 1990 and 2019, and decomposed the time trends and country differences into the unique contributions of the different underlying causes of death and disability.
RESULTS: Life expectancy (LE) in Belgium improved significantly between 1990 and 2019 for both men and women. Belgium age-standardised mortality rates dropped significantly for men (-40%) and women (-33%) between 1990 and 2019. Overall, Belgium age-standardised disability-adjusted life year (DALY) rates dropped by 23%. This decrease is mainly due to decreasing trends in age-standardised years of life lost (YLL) rates while age-standardised years lived with disability (YLD) rates remained stable. Compared to EU-15, Belgium's ranking in terms of age-standardised DALY rates worsened for both men and women in 2019. Self-harm and falls are major causes of disease burden, with DALY rates that are higher than in many other EU-15 countries, indicating a realistic potential for improvement. Lung cancer DALY rates remain worrisome for men, and even show an increasing trend for women. Increasing trends of headache disorders, drug use disorders, and diabetes, require further attention.
CONCLUSION: Non-communicable diseases remain the main contributors for health burden in Belgium, with disability accounting for an increasingly larger share of the disease burden. Despite considerable improvements, Belgium's ranking for DALYs decreased between 1990 and 2019 compared to the EU-15. This study identified priority causes of disease burden based on their contributions to current evolutions and EU-15 differences. Since many of these causes are considered to be avoidable, primary and secondary prevention are crucial elements for reducing the burden of disease on the healthcare system.
© 2022. The Author(s).

Entities:  

Keywords:  Burden of disease; Disability-Adjusted Life Years; Public health monitoring

Year:  2022        PMID: 36258249      PMCID: PMC9580164          DOI: 10.1186/s13690-022-00976-2

Source DB:  PubMed          Journal:  Arch Public Health        ISSN: 0778-7367


  24 in total

1.  Belgium: Health System Review.

Authors:  Sophie Gerkens; Sherry Merkur
Journal:  Health Syst Transit       Date:  2020-12

2.  Monitoring country progress and achievements by making global predictions: is the tail wagging the dog?

Authors:  Ties Boerma; Cesar Victora; Carla Abouzahr
Journal:  Lancet       Date:  2018-04-13       Impact factor: 79.321

3.  Cardiovascular disease in Europe 2014: epidemiological update.

Authors:  Melanie Nichols; Nick Townsend; Peter Scarborough; Mike Rayner
Journal:  Eur Heart J       Date:  2014-08-19       Impact factor: 29.983

4.  Social Inequalities in Cancer Survival in Belgium: A Population-Based Cohort Study.

Authors:  Michael Rosskamp; Julie Verbeeck; Victoria Sass; Sylvie Gadeyne; Freija Verdoodt; Harlinde De Schutter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-10-20       Impact factor: 4.254

Review 5.  Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement.

Authors:  Gretchen A Stevens; Leontine Alkema; Robert E Black; J Ties Boerma; Gary S Collins; Majid Ezzati; John T Grove; Daniel R Hogan; Margaret C Hogan; Richard Horton; Joy E Lawn; Ana Marušić; Colin D Mathers; Christopher J L Murray; Igor Rudan; Joshua A Salomon; Paul J Simpson; Theo Vos; Vivian Welch
Journal:  Lancet       Date:  2016-06-28       Impact factor: 79.321

Review 6.  Five insights from the Global Burden of Disease Study 2019.

Authors: 
Journal:  Lancet       Date:  2020-10-17       Impact factor: 202.731

7.  Does the Belgian diabetes type 2 care trajectory improve quality of care for diabetes patients?

Authors:  Viviane F A Van Casteren; Nathalie H E Bossuyt; Sarah J S Moreels; Geert Goderis; Katrien Vanthomme; Johan Wens; Etienne W De Clercq
Journal:  Arch Public Health       Date:  2015-07-13

8.  Changes in health in Belgium, 1990-2016: a benchmarking analysis based on the global burden of disease 2016 study.

Authors:  C Maertens de Noordhout; H Van Oyen; N Speybroeck; B Devleesschauwer
Journal:  BMC Public Health       Date:  2018-06-20       Impact factor: 3.295

9.  Understanding and meeting the needs of the older population: a global challenge.

Authors:  Howard Bergman; Sathya Karunananthan; Luis M G Robledo; Jenny Brodsky; Piu Chan; Maria Cheung; Pascal Bovet
Journal:  Can Geriatr J       Date:  2013-06-03

10.  Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.

Authors: 
Journal:  Lancet       Date:  2020-10-17       Impact factor: 202.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.